Roles of ATM and ATR Kinases in DNA Damage Responses
Roles of ATM and ATR Kinases in DNA Damage Responses
批准号:
6555197
负责人:
ROBERT T ABRAHAM
金额:
$39.65万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-03-01 至 2006-02-28
关键词:
DNA damage DNA repair brca gene cell cycle proteins cell line enzyme activity ionizing radiation neoplasm /cancer genetics oncoproteins phosphoproteins phosphorylation protein kinase radiation carcinogen radiation carcinogenesis radiation genetics radiation related neoplasm /cancer radiation resistance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Cell-cycle checkpoints are signal transduction pathways that ensure orderly
progression of the cell cycle, and that proliferating cells do not attempt to
replicate or segregate damaged chromosomes. Recent studies have pinpointed two
members of the P1 3-kinase related kinase family, ATM and ATR, as proximal
signaling elements in the G1, S, and G2 checkpoint pathways. The emerging view
is that ATM function is required for the induction of appropriate checkpoint
responses to ionizing radiation-induced DNA double-strand breaks, while ATR
plays dominant roles in the responses to ultraviolet light induced DNA damage,
as well as to DNA replicative stress induced by drugs or intrinsic errors
associated with DNA metabolism. In spite of this progress, the mechanisms
underlying the regulation and function of ATR remain unclear, due in large part
to the lack of a genetically tractable, ATR-deficient cellular model system.
Similarly, although our preliminary studies have identified two important
genome surveillance proteins, BRCA1 and hRad17, as substrates for the ATM/ATR
kinases in DNA-damaged cells, the functional consequences of these
phosphorylation events have not been defined. This project will address these
critical issues through implementation of the following specific aims: (1) To
complete the generation of a novel ATR-/- cell line, and to characterize the
checkpoint signaling defects in these cells, and (2) To determine the impact of
ATR-mediated phosphorylation on the genome maintenance functions of BRCA1,
through the use of two newly described functional assays for BRCA1, (3) To
define the regulatory effects of ATR/ATM-dependent phosphorylation on the
checkpoint signaling functions of hRad17, and (4) To identify and functionally
characterize novel SIT-Q-containing substrates for ATR and ATM in cells exposed
to genotoxic stress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
KINASE TARGETS IN HYPOXIC CANCER CELLS
-
批准号:6923492
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2005
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Developmental Pilot Project 2
-
批准号:6990460
-
项目类别:
-
资助金额:$4.43万
-
财政年份:2004
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Roles of ATM and ATR Kinases in DNA Damage Responses
-
批准号:6640664
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2002
-
负责人:ROBERT T ABRAHAM
-
依托单位:
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY
-
批准号:6650587
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2002
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Roles of ATM and ATR Kinases in DNA Damage Responses
-
批准号:6706268
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2002
-
负责人:ROBERT T ABRAHAM
-
依托单位:
NEW TRANSLATION INITIATION INHIBITORS FOR CANCER THERAPY
-
批准号:6496689
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2001
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6300373
-
项目类别:
-
资助金额:$16.56万
-
财政年份:2000
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6102644
-
项目类别:
-
资助金额:$16.56万
-
财政年份:1999
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL-CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6269456
-
项目类别:
-
资助金额:$15.96万
-
财政年份:1998
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:6124431
-
项目类别:
-
资助金额:$21.11万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:2448920
-
项目类别:
-
资助金额:$18.49万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:2837767
-
项目类别:
-
资助金额:$20.49万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Cellular Pharmacology of Rapamycin
-
批准号:6574185
-
项目类别:
-
资助金额:$33.6万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CANCER CENTER SUPPORT GRANT
-
批准号:6768018
-
项目类别:
-
资助金额:$340.0万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
Cellular Pharmacology of Rapamycin
-
批准号:6712826
-
项目类别:
-
资助金额:$33.6万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELL-CYCLE TARGETS FOR ANTICANCER DRUGS
-
批准号:6237156
-
项目类别:
-
资助金额:$15.36万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:6617287
-
项目类别:
-
资助金额:$14.78万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
CELLULAR PHARMACOLOGY OF RAPAMYCIN
-
批准号:6329001
-
项目类别:
-
资助金额:$6.96万
-
财政年份:1997
-
负责人:ROBERT T ABRAHAM
-
依托单位:
SIGNAL TRANSDUCTION FROM THE T CELL ANTIGEN RECEPTOR
-
批准号:2701553
-
项目类别:
-
资助金额:$4.96万
-
财政年份:1992
-
负责人:ROBERT T ABRAHAM
-
依托单位:
SIGNAL TRANSDUCTION FROM THE T CELL ANTIGEN RECEPTOR
-
批准号:2184688
-
项目类别:
-
资助金额:$19.13万
-
财政年份:1992
-
负责人:ROBERT T ABRAHAM
-
依托单位:
海外基金